Actively Recruiting
INTERogating Cancer for Etiology, Prevention, and Therapy Navigation Using Pan-Genomic Testing in Patients with Cancer
Led by Mayo Clinic · Updated on 2026-10-16
500
Participants Needed
5
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating cancer by analyzing genetic material such as DNA and RNA from patients with confirmed cancer diagnoses. This observational study aims to identify genetic markers and causes of cancer, helping to improve prevention, screening, and treatment. The study also seeks to create a biobank of samples and information to support future cancer research. Participants undergo pan-genomic testing where samples like blood, saliva, bone marrow, hair follicles, or archived tissue are collected and analyzed for genetic changes. There are different groups based on testing types, including germline and somatic testing. Results are returned to the participants care teams and uploaded to patient portals. If certain hereditary genetic variants are found, participants may be referred to genetic counselors for further review. During the study, participants provide samples and medical information, and their genomic data may be collected from previous tests when available. Researchers measure genetic sequences from tumors and blood as the primary outcome. Participation is indefinite unless withdrawn. The study involves genetic sequencing and ongoing data collection to enhance understanding of cancer genetics and support personalized care.
CONDITIONS
Brief Title
INTERogating Cancer for Etiology, Prevention and Therapy Navigation
Research Team
C
Cancer Center CRC Team
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here